Guangdong Wannianqing (301111.SZ) announced that Huayin International Pharmaceutical Port Group (Shantou) Co., Ltd., a wholly-owned subsidiary of the company...
Zhitong Finance App News, Guangdong Wannianqing (301111.SZ) announced that Huayin International Pharmaceutical Port Group (Shantou) Co., Ltd. (“Pharmaceutical Port”), a wholly-owned subsidiary of the company, plans to jointly invest with Guangzhou Noah Investment and Development Co., Ltd. (“Noah Investment”) and Chen Xiuyan to establish Shantou Noah Weikang Medical Management Co., Ltd. (tentative name, abbreviation: “Joint Venture Company”), with a registered capital of 10 million yuan, of which Pharmaceutical Port will pay an amount of 5.6 million yuan. It accounts for 56.00% of the registered capital.
This joint investment with Noah Investment and Chen Xiuyan is based on the needs of future big health industry development strategies. By gathering the experience and resources of various shareholders in the field of healthcare services, the company quickly lays out the healthcare management service industry, promotes and operates a comprehensive outpatient department with the “Noah Healthcare” brand, extending the company's big health industry chain and achieving the company's future sustainable development.